Catamaran Bio

Catamaran Bio is a biotechnology company that researches and develops allogeneic CAR-NK cell therapies for the treatment of cancer. Read more

1 Followers on Owler
1 Followers on Owler
1 Followers on Owler
1 Followers on Owler

Catamaran Bio

Catamaran Bio is a biotechnology company that researches and develops allogeneic CAR-NK cell therapies for the treatment of cancer. Read more

Alvin Shih's photo - President & CEO of Catamaran Bio

President & CEO

Alvin Shih

CEO Approval Rating

90/100

Founded:

2020

Status:

PrivateIndependent Company

CATAMARAN BIO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Nkarta is perceived as one of Catamaran Bio's biggest rivals. Nkarta is headquartered in South San Francisco, California, and was founded in 2015. Like Catamaran Bio, Nkarta also operates in the Biotechnology industry. Nkarta generates 2.31% the revenue of Catamaran Bio.

Dragonfly is one of Catamaran Bio's top competitors. Dragonfly is a Private company that was founded in 2015 in Waltham, Massachusetts. Like Catamaran Bio, Dragonfly also operates in the Biotechnology field. Compared to Catamaran Bio, Dragonfly has 57 more employees.

Kiadis Pharma has been one of Catamaran Bio's top competitors. Kiadis Pharma was founded in 1997 in Amsterdam, Zuid-Holland. Like Catamaran Bio, Kiadis Pharma also works within the Pharmaceuticals field. Kiadis Pharma generates $ less revenue than Catamaran Bio.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $5M a good estimate for Catamaran Bio's revenue?

Catamaran Bio Acquisitions

No recent acquisitions found related to Catamaran Bio

Catamaran Bio Funding History

$42M

Since Catamaran Bio was founded in 2020, it has participated in 1 round of funding. In total Catamaran Bio has raised $42.0M. Catamaran Bio's funding round was on Nov 2020 for a total of $42.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Nov 2020
$42M

Sofinnova Partners

Since Catamaran Bio was founded in 2020, it has participated in 1 round of funding. In total Catamaran Bio has raised $42.0M. Catamaran Bio's funding round was on Nov 2020 for a total of $42.0M

Catamaran Bio Investments

No recent investments found related to Catamaran Bio

Catamaran Bio News

November 23, 2020MarketScreener

Catamaran Bio Launches with $42 Million Financing to Develop OfftheShelf CAR-NK Cell Therapies to Treat Solid Tumors

(marketscreener.com) Company brings together scientific founders with leading-edge expertise in NK ce... See more »

Social Media

Catamaran Bio Headquarters

610 Main Street

Cambridge, Massachusetts02139

Driving Directions »

Trending Companies

Catamaran Bio Summary

ABOUT

Overview

Catamaran Bio is a biotechnology company that researches and develops allogeneic CAR-NK cell therapies for the treatment of cancer. Catamaran Bio was founded in 2020. Catamaran Bio's headquarters is located in Cambridge, Massachusetts, USA 02139. It h...

CEO

Catamaran Bio's President & CEO, Alvin Shih, currently has an approval rating of 90%. Catamaran Bio's primary competitors are Nkarta, Dragonfly & Kiadis Pharma.

Website

catamaranbio.com

Frequently Asked Questions about Catamaran Bio

  1. When was Catamaran Bio founded?

    Catamaran Bio was founded in 2020
  2. Who is Catamaran Bio's CEO?

    Catamaran Bio's CEO is Alvin Shih
  3. How much revenue does Catamaran Bio generate?

    Catamaran Bio generates $5M in revenue
  4. How much funding does Catamaran Bio have?

    Catamaran Bio has historically raised $42M in funding
  1. Where is Catamaran Bio's headquarters?

    Catamaran Bio's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Catamaran Bio have?

    Catamaran Bio has 23 employees
  3. What sector does Catamaran Bio operate in?

    Catamaran Bio is in Pharmaceuticals, Biotechnology
  4. Who are Catamaran Bio's competitors?

    Catamaran Bio's top competitors are Nkarta, Dragonfly, Kiadis Pharma